In an increasingly demanding regulatory environment, pharmaceutical companies, biotech firms, marketing authorization holders, CROs and life sciences organizations must ensure the compliance of their vigilance activities while strengthening patient safety and managing regulatory risks effectively.

Pharmacovigilance and other safety vigilance activities are no longer limited to operational requirements: they have become a strategic priority for governance, quality, compliance and inspection readiness with health authorities.

Atessia Vigilances supports its clients in structuring, overseeing and optimizing their vigilance systems across France and Europe through an expert, pragmatic and inspection-ready approach.

Our objective: to safeguard your regulatory obligations, enhance the quality of your safety data and ensure the long-term compliance of your vigilance activities.